A German multicenter, randomized phase III trial comparing irinotecan–carboplatin with etoposide–carboplatin as first-line therapy for extensive-disease small-cell lung cancer
- Resource Type
- Article
- Source
- In
Annals of Oncology August 2011 22(8):1798-1804 - Subject
- Language
- ISSN
- 0923-7534